# Movetis clinical trials: 24 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials with Movetis as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Movetis: 24 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/movetis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 28, 2012 | NCT01674192 | Prucalopride Subjects With Renal Impairment | Movetis | Phase 1 | Completed | Constipation | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01674192) |
| August 28, 2012 | NCT01674166 | Single Dose Pharmacokinetics of Prucalopride in Paediatric Subjects, With Functional Faecal Retention | Movetis | Phase 1 | Completed | Constipation | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01674166) |
| August 22, 2012 | NCT01670669 | Prucalopride in Paediatric Subjects, With Functional Faecal Retention | Movetis | Phase 1 | Completed | Constipation | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01670669) |
| August 11, 2010 | NCT01179607 | Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or Normonatraemia | Movetis | Phase 2 | Completed | Cirrhotic Ascites | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01179607) |
| May 31, 2010 | NCT01134185 | Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic Impairment | Movetis | Phase 1 | Completed | Hepatic Impairment | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01134185) |
| February 18, 2010 | NCT01070615 | Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic Constipation | Movetis | Phase 3 | Completed | Chronic Constipation | 693 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01070615) |
| December 21, 2009 | NCT01036893 | M0001 Effects on Oral Contraceptive Plasma Levels | Movetis | Phase 1 | Completed | Healthy Volunteers | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01036893) |
| October 1, 2009 | NCT00987844 | Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic Constipation | Movetis | Phase 3 | Completed | Chronic Constipation | 1,775 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00987844) |
| May 18, 2009 | NCT00903747 | Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG Parameters | Movetis | Phase 1 | Completed | Constipation | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00903747) |
| November 19, 2008 | NCT00793429 | Safety Study of Prucalopride in Healthy Volunteers | Movetis | Phase 1 | Completed | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00793429) |
| November 19, 2008 | NCT00793247 | Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP) | Movetis | Phase 2 | Completed | Chronic Intestinal Pseudo-Obstruction | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00793247) |
| March 10, 2008 | NCT00631813 | Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation | Movetis | Phase 2 | Completed | Constipation | 253 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00631813) |
| March 3, 2008 | NCT00627692 | Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing Facility | Movetis | Phase 2 | Completed | Constipation | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00627692) |
| February 18, 2008 | NCT00617513 | Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation | Movetis | Phase 2 | Completed | Constipation | 174 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00617513) |
| January 21, 2008 | NCT00598338 | Efficacy and Safety Study of Prucalopride for the Re-Treatment of Chronic Constipation | Movetis | Phase 3 | Completed | Constipation | 516 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00598338) |
| January 17, 2008 | NCT00596596 | Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation | Movetis | Phase 2 | Completed | Constipation | 313 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00596596) |
| December 19, 2007 | NCT00577018 | Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic Constipation | Movetis | Phase 3 | Completed | Constipation | 755 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00577018) |
| December 19, 2007 | NCT00576511 | Effect of Prucalopride in Patients With Severe Chronic Idiopathic Constipation | Movetis | Phase 2 | Completed | Chronic Constipation | 53 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00576511) |
| December 18, 2007 | NCT00575614 | Prucalopride in Patients With Chronic Idiopathic Constipation | Movetis | Phase 2 | Completed | Constipation | 87 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00575614) |
| June 20, 2007 | NCT00488215 | A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety of Prucalopride | Movetis | Phase 1 | Completed | Constipation | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00488215) |
| June 19, 2007 | NCT00488137 | Efficacy and Safety Study of Prucalopride to Treat Chronic Constipation | Movetis | Phase 3 | Completed | Constipation | 716 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00488137) |
| June 18, 2007 | NCT00487422 | Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic Constipation | Movetis | Phase 3 | Completed | Constipation | 303 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00487422) |
| June 13, 2007 | NCT00485940 | Efficacy and Safety Study of Prucalopride for the Treatment of Patients With Chronic Constipation | Movetis | Phase 3 | Completed | Constipation | 641 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00485940) |
| June 7, 2007 | NCT00483886 | Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation | Movetis | Phase 3 | Completed | Constipation | 620 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00483886) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 8 |
| Phase 2 | 8 |
| Phase 3 | 8 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 24 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Constipation | 17 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Marble and granite professional companies in the United States](https://specstream.ai/data/businesses/marble-and-granite-professional-companies/united-states)
- [Basque restaurants in the United States](https://specstream.ai/data/businesses/basque-restaurants/united-states)
- [Oral and maxillofacial surgery practices in the United States](https://specstream.ai/data/businesses/oral-and-maxillofacial-surgery-practices/united-states)
- [Cheesesteak restaurants in the United States](https://specstream.ai/data/businesses/cheesesteak-restaurants/united-states)
- [Prenatal and perinatal care clinics in the United States](https://specstream.ai/data/businesses/prenatal-and-perinatal-care-clinics/united-states)
- [Dental hygiene clinics in the United States](https://specstream.ai/data/businesses/dental-hygiene-clinics/united-states)
